Thursday, 3 Jul 2025
About Us
Contact Us
Terms and Conditions
Privacy Policy
Subscribe
Home
Business
Business Wire
Globenews Wire
News
News
Show More
Hon’ble MP Dr. Ashok Kumar Mittal Highlights India’s Commitment to Global Cooperation and Anti-Terrorism During Slovenia Visit
Big Bang Boom Solutions Accelerates Deployment of the Indigenous Vajra Sentinel System to the Indian Air Force in Response to Operation Sindoor
Kalam & Kavach 2.0 Conclave Charts Roadmap for Defence Reforms, Innovation and Self-Reliance in 2025
PR Newswire Expands Reach in Singapore via SPH Media Partnership
Quest Global and IEEE India support women engineering students and returning women engineers through Corporate Social Responsibility (CSR) initiatives
Tech
Health
Sports
Entertainment
Automobile
🔥
june
Business
global
today
announced
Tech
company
globe
newswire
will
Home
Business
News
Tech
Health
Sports
Entertainment
Automobile
Search
Home
Business
Business Wire
Globenews Wire
News
Tech
Health
Sports
Entertainment
Automobile
Follow US
Tag:
combination
BioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific Sessions
13171229 B.C. Ltd. and Launchit Solutions Inc. Announce Execution of Business Combination Agreement and Launchits Concurrent Financing
HUTCHMED and Innovent Jointly Announce NDA Acceptance in China for Fruquintinib Combination with Sintilimab for the Treatment of Advanced Renal Cell Carcinoma
Roches Tecentriq combined with lurbinectedin shows significant survival benefit in extensive-stage small cell lung cancer
HOTEL101 PROGRESSES TOWARDS NASDAQ LISTING
Novartis Pluvicto demonstrates statistically significant and clinically meaningful rPFS benefit in patients with PSMA-positive metastatic hormone-sensitive prostate cancer
Initial Data from the ARC-20 Study of Casdatifan Plus Cabozantinib Showed Nearly Half of Patients with Metastatic Kidney Cancer Had a Confirmed Response
DATROWAY Continues to Show Promising Tumor Responses as Part of Combination Regimens in Patients with Early and Advanced Non-Small Cell Lung Cancer
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Avistone Announces Encouraging Results for Vebreltinib plus Andamertinib (PLB1004) in EGFR-mutated NSCLC with MET Amplification or Overexpression at ASCO Annual Meeting 2025
Username or Email Address
Password
Remember me
Lost your password?
